Anheuser-Busch InBev SA/NV (1NBA.DE)
EUR 48.92
(-1.35%)
EUR 48.92
(-1.35%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 59.38 Billion | 57.78 Billion | 54.3 Billion | 46.88 Billion | 52.32 Billion | 54.61 Billion |
| Cost of Revenue | 27.39 Billion | 26.3 Billion | 23.09 Billion | 19.63 Billion | 20.36 Billion | 20.35 Billion |
| Gross Profit | 31.98 Billion | 31.48 Billion | 31.2 Billion | 27.24 Billion | 31.96 Billion | 34.26 Billion |
| Operating Expenses | 18.01 Billion | 17.21 Billion | 17.22 Billion | 14.52 Billion | 16.2 Billion | 17.1 Billion |
| Selling, General and Administrative Expenses | 18.17 Billion | 17.55 Billion | 17.57 Billion | 15.36 Billion | 16.42 Billion | 17.11 Billion |
| Research and Development Expenses | - | 268 Million | 298 Million | 296 Million | 291 Million | 276 Million |
| Other Expenses | -155 Million | -338 Million | -346 Million | -845 Million | -221 Million | 249 Million |
| Cost and Expenses | 45.41 Billion | 43.52 Billion | 40.32 Billion | 34.15 Billion | 36.56 Billion | 37.46 Billion |
| Operating Income | 13.96 Billion | 14.51 Billion | 13.82 Billion | 7.8 Billion | 16.09 Billion | 17.1 Billion |
| Interest Expense | 4.59 Billion | 4.44 Billion | 5.23 Billion | 4.99 Billion | 4.89 Billion | 4.61 Billion |
| Income Tax Expense | 2.23 Billion | 1.92 Billion | 2.35 Billion | 1.93 Billion | 2.78 Billion | 2.83 Billion |
| Earnings before Tax | 9.12 Billion | 9.52 Billion | 8.46 Billion | 2.08 Billion | 12.77 Billion | 8.53 Billion |
| Net Income | 5.34 Billion | 5.96 Billion | 4.67 Billion | 148 Million | 9.17 Billion | 4.36 Billion |
| Earnings Per Share Basic | 2.60 | 2.99 | 2.33 | 0.08 | 4.62 | 2.21 |
| Earnings Per Share Diluted | 2.60 | 2.93 | 2.28 | 0.07 | 4.53 | 2.17 |
| Weighted Average Shares Outstanding | 2.05 Billion | 2.01 Billion | 2 Billion | 1.96 Billion | 1.98 Billion | 1.97 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.05 Billion | 2.03 Billion | 2.04 Billion | 1.98 Billion | 2.02 Billion | 2.01 Billion |
| Gross Margin | 0.54 | 0.54 | 0.57 | 0.58 | 0.61 | 0.63 |
| EBIT Margin | 0.32 | 0.33 | 0.36 | 0.27 | 0.42 | 0.37 |
| Profit Margin | 0.09 | 0.10 | 0.09 | 0.00 | 0.18 | 0.08 |
| EBITDA | 19.12 Billion | 19.04 Billion | 19.29 Billion | 16.93 Billion | 22.32 Billion | 21.62 Billion |
| Earnings Before Tax Margin | 0.24 | 0.25 | 0.25 | 0.17 | 0.31 | 0.31 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 15.04 Billion | 15.33 Billion | 14.54 Billion | 59.38 Billion | 14.47 Billion | 15.57 Billion |
| Cost of Revenue | 6.68 Billion | 6.76 Billion | 6.65 Billion | 27.39 Billion | 6.67 Billion | 7.18 Billion |
| Gross Profit | 8.36 Billion | 8.56 Billion | 7.89 Billion | 31.98 Billion | 7.79 Billion | 8.39 Billion |
| Operating Expenses | 4.27 Billion | 4.66 Billion | 4.25 Billion | 17.39 Billion | 4.3 Billion | 4.36 Billion |
| Selling, General and Administrative Expenses | 4.49 Billion | 4.81 Billion | 4.43 Billion | - | 4.53 Billion | 4.58 Billion |
| Research and Development Expenses | - | - | - | - | 256 Million | - |
| Other Expenses | -215 Million | -90 Million | - | -12 Million | -12 Million | - |
| Cost and Expenses | 10.95 Billion | 11.42 Billion | 10.9 Billion | 44.79 Billion | 10.98 Billion | 11.54 Billion |
| Operating Income | 4.09 Billion | 3.9 Billion | 3.64 Billion | 13.83 Billion | 3.21 Billion | 4.02 Billion |
| Interest Expense | 904 Million | 960 Million | 927 Million | 4.02 Billion | 966 Million | 1 Billion |
| Income Tax Expense | 758 Million | 752 Million | 794 Million | 2.23 Billion | 376 Million | 666 Million |
| Earnings before Tax | 3.24 Billion | 2.5 Billion | 2.27 Billion | 9.12 Billion | 2.64 Billion | 2.63 Billion |
| Net Income | 2.07 Billion | 1.47 Billion | 1.09 Billion | 5.34 Billion | 1.89 Billion | 1.47 Billion |
| Earnings Per Share Basic | 1.03 | 1.18 | 0.54 | - | 0.94 | 0.73 |
| Earnings Per Share Diluted | 1.01 | 1.16 | 0.54 | - | 0.94 | 0.73 |
| Weighted Average Shares Outstanding | 2 Billion | 2 Billion | 2 Billion | 2.01 Billion | 1.98 Billion | 2.01 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.04 Billion | 2.04 Billion | 2 Billion | 2.01 Billion | 2.01 Billion | 2.01 Billion |
| Gross Margin | 0.56 | 0.56 | 0.54 | 0.54 | 0.54 | 0.54 |
| EBIT Margin | 0.28 | 0.24 | 0.24 | - | 0.22 | 0.25 |
| Profit Margin | 0.14 | 0.10 | 0.07 | 0.09 | 0.13 | 0.09 |
| EBITDA | 4.15 Billion | 3.68 Billion | 3.54 Billion | - | 3.21 Billion | 3.9 Billion |
| Earnings Before Tax Margin | 0.27 | 0.25 | 0.25 | 0.23 | 0.22 | 0.26 |
AXCP
BAJAJHIND
COSCO
JOHNPHARMA
GML
2125